DK675489A - Anvendelse af tpa-varianter til fremstilling af et terapeutisk praeparat til behandling af vaskulaere sygdomme - Google Patents

Anvendelse af tpa-varianter til fremstilling af et terapeutisk praeparat til behandling af vaskulaere sygdomme Download PDF

Info

Publication number
DK675489A
DK675489A DK675489A DK675489A DK675489A DK 675489 A DK675489 A DK 675489A DK 675489 A DK675489 A DK 675489A DK 675489 A DK675489 A DK 675489A DK 675489 A DK675489 A DK 675489A
Authority
DK
Denmark
Prior art keywords
preparation
tpa
variations
treatment
application
Prior art date
Application number
DK675489A
Other languages
English (en)
Other versions
DK175369B1 (da
DK675489D0 (da
Inventor
Deborah L Higgins
William E Holmes
Adair J Hotchkiss
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27371343&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK675489(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US07/188,237 external-priority patent/US4935237A/en
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of DK675489D0 publication Critical patent/DK675489D0/da
Publication of DK675489A publication Critical patent/DK675489A/da
Application granted granted Critical
Publication of DK175369B1 publication Critical patent/DK175369B1/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424Serine endopeptidases (3.4.21)
    • C12N9/6456Plasminogen activators
    • C12N9/6459Plasminogen activators t-plasminogen activator (3.4.21.68), i.e. tPA
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y304/00Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21Serine endopeptidases (3.4.21)
    • C12Y304/21069Protein C activated (3.4.21.69)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK198906754A 1987-06-30 1989-12-29 Anvendelse af tPA-varianter til fremstilling af et terapeutisk præparat til behandling af vaskulæresygdomme DK175369B1 (da)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US6844887A 1987-06-30 1987-06-30
US6844887 1987-06-30
US17097088A 1988-03-21 1988-03-21
US17097088 1988-03-21
US07/188,237 US4935237A (en) 1988-03-21 1988-04-29 Processes for the preparation of t-PA mutants
US18823788 1988-04-29
PCT/US1988/002175 WO1989000197A1 (en) 1987-06-30 1988-06-27 Improved processes for the treatment of vascular disease
US8802175 1988-06-27

Publications (3)

Publication Number Publication Date
DK675489D0 DK675489D0 (da) 1989-12-29
DK675489A true DK675489A (da) 1990-02-28
DK175369B1 DK175369B1 (da) 2004-09-13

Family

ID=27371343

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198906754A DK175369B1 (da) 1987-06-30 1989-12-29 Anvendelse af tPA-varianter til fremstilling af et terapeutisk præparat til behandling af vaskulæresygdomme

Country Status (7)

Country Link
EP (1) EP0365597B2 (da)
JP (2) JPH02504102A (da)
CA (1) CA1340942C (da)
DE (1) DE3886755T3 (da)
DK (1) DK175369B1 (da)
NZ (1) NZ225200A (da)
WO (1) WO1989000197A1 (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2534332B2 (ja) * 1987-10-29 1996-09-11 山之内製薬株式会社 ポリペプチド化合物
US5714145A (en) * 1988-09-02 1998-02-03 Genentech, Inc. Tissue plasminogen activator having zymogenic or fibrin specific properties
US5262170A (en) * 1988-09-02 1993-11-16 Genentech, Inc. Tissue plasminogen activator having zymogenic or fibrin specific properties and substituted at amino acid positions 296-299, DNA molecules encoding them, vectors, and host cells
EP0462651A1 (en) * 1990-06-15 1991-12-27 Leuven Research & Development V.Z.W. Chimeric plasminogen activators
ES2082465T3 (es) * 1991-04-16 1996-03-16 Boehringer Mannheim Gmbh Unidad farmaceutica de envasado que contiene activadores de plasminogeno para la administracion multiple de bolos.
DK0643772T3 (da) * 1992-06-03 1998-02-02 Genentech Inc Glycosyleringsvarianter af vævsplasminogenaktivator med forbedrede terapeutiske egenskaber
DK0827751T3 (da) * 1996-09-06 2003-03-31 Chemo Sero Therapeut Res Inst Medicinsk præparat indeholdende vævsplasminogenaktivator og nicotinamid

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8508717D0 (en) * 1985-04-03 1985-05-09 Beecham Group Plc Composition
GR860875B (en) * 1985-04-04 1986-07-29 Beecham Group Plc Novel compounds
HU206520B (en) * 1985-04-22 1992-11-30 Genentech Inc Process for producing new human tissue plasminogen activator /tpa/ mutants and pharmaceutical compositions containing them
NZ217331A (en) * 1985-08-26 1989-05-29 Lilly Co Eli Tissue plasminogen activator derivatives and genetically engineered product
EP0293394B2 (en) * 1986-01-31 2003-10-29 Genetics Institute, LLC Novel thrombolytic proteins

Also Published As

Publication number Publication date
NZ225200A (en) 1991-03-26
EP0365597B1 (en) 1993-12-29
DE3886755T2 (de) 1994-05-26
CA1340942C (en) 2000-04-04
DE3886755D1 (de) 1994-02-10
JPH02504102A (ja) 1990-11-29
WO1989000197A1 (en) 1989-01-12
DE3886755T3 (de) 2005-12-08
DK175369B1 (da) 2004-09-13
DK675489D0 (da) 1989-12-29
JPH1080271A (ja) 1998-03-31
EP0365597B2 (en) 2005-02-09
EP0365597A1 (en) 1990-05-02

Similar Documents

Publication Publication Date Title
DK545088A (da) Doseringsform til behandling af kardiovaskulaere sygdomme
DK217188A (da) Farmaceutisk praeparat til behandling af neurologiske sygdomme
DK333788D0 (da) Farmaceutisk praeparat til behandling af oedelagt bruskvaev
NO884052D0 (no) Fremgangsmaate for fremstilling av et terapeutisk preparat.
NO883485D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive piperidinyl-isokinolinforbindelser.
NO881643L (no) Fremgangsmaate for fremstilling av hoeystabile mykgelatinkapsler for terapeutiske formaal.
NO167797C (no) Analogifremgangsmaate for fremstilling av et terapeutisk aktivt nitrometan.
NO870866D0 (no) Fremgangsmaate for fremstilling av et terapeutisk kombinasjonspreparat.
NO880667D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive arylpiperazinyl-alkylen-fenyl-heterocykliske forbindelser.
NO168100C (no) Analogifremgangsmaate for fremstilling av et terapeutisk aktivt fenolderivat
DK675489A (da) Anvendelse af tpa-varianter til fremstilling af et terapeutisk praeparat til behandling af vaskulaere sygdomme
DK473088A (da) Anvendelse af 2-amino-6-trifluormethoxybenzothiazol til fremstilling af et laegemiddel
DK473288D0 (da) Anvendelse af 2-amino-6-trifluormethoxybenzothiazol til fremstilling af et laegemiddel
DK10188A (da) Middel til behandling af virussygdomme
DK651588A (da) Anvendelse af en forbindelse til fremstilling af et farmaceutisk praeparat til behandling af fibromyalgia
NO882281D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyrazinamider.
NO873571D0 (no) Fremgangsmaate for fremstilling av et terapeutisk virksomt preparat.
DK639088D0 (da) Laegemiddel til behandling af iskaemiske hjertesygdomme
NO883959D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive fenolestere.
NO882282L (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyrazinamider.
DK83688D0 (da) Anvendelse af kendte forbindelser til fremstilling af et laegemiddel til behandling af hjertesygdomme eller organisk hjernesyndrom
NO863225L (no) Analogifremgangsmaate for fremstilling av et terapeutisk virksomt benzodioxepan.
DK681288D0 (da) Aenootropt terapeutisk laegemiddelae
DK102488D0 (da) Praeparat til behandling af tandsygdomme
DK473188D0 (da) Anvendelse af 2-amino-6-trifluormethoxybenzothiazol til fremstilling af et laegemiddel

Legal Events

Date Code Title Description
PUP Patent expired